BIOMASON
Biomason is a developer of a building materials technology to produce biological cement-based building materials alternatives. Its bio cement production combines natural microorganisms and chemical processes to develop masonry materials at room temperature, which helps replace traditional clay and concrete, and the high energy consumption associated with standard manufacturing them, enabling builders to acquire alternative building materials that are produced carbon-free. Since 2012, the compan... y has used microorganisms to grow sustainable, structural biocementยฎ in ambient temperatures, harnessing the power of biotechnology to reinvent traditional cement and offer a planet-friendly alternative. Biocement will eliminate 25% of the concrete industryโs global carbon emissions by 2030. Biomason bio cement is in use in projects throughout the US and Europe, and bioLITH precast tile products are commercially available.
BIOMASON
Industry:
Biotechnology Building Material Industrial
Founded:
2012-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.biomason.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
94.95 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Domain Not Resolving Wordpress Plugins Sitelinks Search Box Organization Schema
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Current Employees Featured
Founder
Investors List
Novo Holdings
Novo Holdings investment in Series C - Biomason
Martin Marietta
Martin Marietta investment in Series C - Biomason
2150
2150 investment in Series C - Biomason
Celesta Capital
Celesta Capital investment in Series C - Biomason
Hartree Partners
Hartree Partners investment in Series C - Biomason
Acorn Innovestments
Acorn Innovestments investment in Venture Round - Biomason
National Science Foundation
National Science Foundation investment in Grant - Biomason
National Science Foundation
National Science Foundation investment in Grant - Biomason
Newest Events participated
Official Site Inspections
http://www.biomason.com Semrush global rank: 2.75 M Semrush visits lastest month: 5.88 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago